Showing results (121-130 of 456) with videos related to
Sort By:
Pageof 46
Neuron|May 6, 2016
PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington's Disease-Associated Phenotypes In VivoJoseph Ochaba, Alex Mas Monteys, Jacqueline G O'Rourke, et al.Biorxiv : the Preprint Server for Biology|September 4, 2024
Generation of humanized mouse models to support therapeutic development for SYNGAP1 and STXBP1 disordersAlex J Felix, Taryn Wilson, Rani Randell, et al.Neuron|January 6, 2015
Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypesJohn H Lee, Luis Tecedor, Yong Hong Chen, et al.JCI Insight|October 2, 2019
Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorderRebecca C Ahrens-Nicklas, Luis Tecedor, Arron F Hall, et al.Journal of Huntington'S Disease|July 27, 2014
Rhes suppression enhances disease phenotypes in Huntington's disease miceJohn H Lee, Matthew J Sowada, Ryan L Boudreau, et al.Current Gene Therapy|November 6, 2007
Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospectsMichael P Seiler, Vincenzo Cerullo, Brendan LeeHuman Molecular Genetics|September 22, 2023
Nitric oxide is required for lung alveolarization revealed by deficiency of argininosuccinate lyaseZixue Jin, Ming-Ming Jiang, Brendan LeeNature Reviews. Genetics|May 19, 2006
Inborn errors of metabolism: the flux from Mendelian to complex diseasesBrendan Lanpher, Nicola Brunetti-Pierri, Brendan LeePlos One|August 29, 2022
Huntington's disease phenotypes are improved via mTORC1 modulation by small molecule therapySophie St-Cyr, Daniel D Child, Emilie Giaime, et al.Human Gene Therapy|March 19, 2009
Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune responsePiotr Hadaczek, John Forsayeth, Hanna Mirek, et al.Pageof 46